TuesdayOct 18, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI) Expanding as Solar Adoption is Projected to Grow by 30% in 2022

Correlate’s strategic investments in clean electrification solutions and commercial solar infrastructure have earned the company a growing customer base, and an opportunity pipeline of over $100 million in commercial projects The company recognizes the rise in EV and solar adoption and looks to tap into this growth to increase its revenues, brand equity, and market reach Todd Michaels, the company’s Founder, President, and CEO, acknowledges that “It has never been a better time for [our] business”  With solar and EV adoption set to grow significantly this year, and with the company’s recent acquisition and planned acquisitions, Correlate is set to…

Continue Reading

TuesdayOct 18, 2022 9:45 am

Odyssey Health, Inc. (ODYY) Updates Progress of its Concussion Drug Development Program; Communicating with the FDA for permission to start phase II clinical trial of its PRV-002 Drug Candidate

Odyssey acquired IP and all rights to PRV-002, its lead drug candidate for the treatment of concussions, on March 1, 2021, and has since made notable progress in a strategic move to have the drug approved by the FDA Since the acquisition, the company has completed IND enabling studies and all cohorts for Phase I SAD and MAD clinical trials for its lead drug candidate In pre-clinical studies PRV-002 has demonstrated equivalent, if not superior neuroprotective effects compared to related neurosteroids, offering proof of reduced behavioral pathology associated with brain injury symptoms, easily crossing the blood-brain barrier to rapidly eliminate…

Continue Reading

TuesdayOct 18, 2022 9:00 am

As Mercedes Sees Market Turning to EVs, Hillcrest Energy Technologies Ltd.’s (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Charging Technology Becomes Increasingly Important

The IEA sees EV sales hitting a record in 2022 after doubling in 2021 from 2020, while noting the lack of charging infrastructure as an obstacle for adoption Hillcrest Energy has developed a new class of inverters that convert DC output from batteries into AC input used by motors in EVs Hillcrest filed a patent application for new tech that eliminates the need for EVs to require and onboard charger, allowing for faster, anywhere charging During an interview last week with CNBC’s Jim Cramer, Mercedes-Benz CEO Ola Kallenius said he is seeing the market for luxury vehicles progressively turning towards…

Continue Reading

MondayOct 17, 2022 2:34 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Featured in BioWorld(TM) MedTech Article

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed an innovative platform for heart attack detection anytime, anywhere, was featured in a recent BioWorld(TM) MedTech article. “HeartBeam Inc. has been awarded a patent for what it called ‘the first and only’ 3D-vector, 12-lead ECG platform for heart attack detection, this in conjunction with a credit card-sized device inside a consumer’s wallet for personal monitoring,” the piece reads. “The company said it can record and remotely transmit a set of cardiac signals to a physician for review so that patients at high risk of cardiac arrest are not left alone…

Continue Reading

MondayOct 17, 2022 1:35 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Continues Focus to Create the Best Psychedelic Therapies for Patients

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is conducting a phase 1/2a trial evaluating CYB003, its lead investigational molecule and the first-ever novel psilocybin analog to enter clinical development. “The in-human trial is critical to the company’s continued development of CYB003, a deuterated psilocybin analog that Cybin believes has potential to successfully address the challenges and limitations of oral psilocybin. According to the company’s preclinical research, CYB003 achieved less variability in plasma levels, along with faster onset of action, improved brain penetration, and shorter duration…

Continue Reading

MondayOct 17, 2022 1:05 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Anticipating 2023 IND Application for Secondary Portfolio Candidate

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is currently conducting a potentially pivotal global phase 2 clinical trial in humans to test the effectiveness of its anti-glioblastoma (“GBM”) drug candidate – Berubicin. Testing of Berubicin resulted in a notable success with evidence of improved survival among a dozen safety trial participants recruited by the drug’s original developer over 15 years ago. In its annual stockholder meeting, the company also provided an update for its secondary drug portfolio WP1244. The anthracycline-based substance, being evaluated for the treatment of brain cancers, ovarian and lymphomas, “has produced a new derivative as WP1874 with…

Continue Reading

MondayOct 17, 2022 12:54 pm

QualityStocksNewsBreaks – Odyssey Health Inc.’s (ODYY) PRV-002 Designed to Mitigate Short- and Long-Term Effects of mTBI

Odyssey Health (OTC: ODYY) early last year acquired PRV-002, a drug candidate for concussed patients to mitigate both short-term and long-term consequences of concussion. Concussion or mTBI “is caused by a jolt, blow or force to the head that changes the brain’s function. This change often results in myriad consequences ranging from emotional and somatic changes to cognitive impairment and physical symptoms… In most cases, concussion symptoms resolve within a few days or weeks as the damaged pathways rebuild and strengthen through repetition, use and cleanup of cell debris. However, there has been growing concern that mTBI may be associated…

Continue Reading

MondayOct 17, 2022 12:00 pm

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Committed to Facilitating BTC Transactions Worldwide via Lightning Network

LQwD is focused on creating enterprise-grade infrastructure to drive bitcoin adoption and, develop institutional-grad services supporting the Lightning Network functionality, transaction capabilities, and bring BTC to scale LQwD Lightning Network nodes include Canada, France, Japan, England, Japan-Osaka, Australia, Italy, Indonesia, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, Ireland, and US-West Currently servicing 17 countries, LQwD plans to increase reach to 24 worldwide by the end of the current quarter The global blockchain market was valued at US $4.67 billion in 2021 and is projected to reach US $7.18 billion in 2022, and then US $163.83…

Continue Reading

MondayOct 17, 2022 11:22 am

QualityStocksNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Partners with LidarSwiss to Create Nano P60 System

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, announced that LidarSwiss Solutions GmbH is deploying its Sora(TM) lidar technology in the company’s drone-based mapping and analytics solution, which is available for infrastructure management and engineering design applications. The full Nano P60 system is on display at the INTERGEO event, held Oct. 18–20, 2022, in Germany. Based in Switzerland, LidarSwiss provides high-performance unmanned aerial vehicle (“UAV”)-based lidar solutions that feature high-fidelity mapping and real-time processing, a key solution for engineers, forestry managers and urban planners. The Nano P60 platform has been used to map and analyze…

Continue Reading

MondayOct 17, 2022 11:15 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Enables Users to Reclaim Online Data; Seeks to Expand Operations Through Acquisition of Multimedia Lists

Data Protection has increasingly become a focus around the globe, with the United States and Europe recently agreeing to implement a joint data privacy framework With one small company said to be successfully hacked every 19 seconds, losses attributed to data breaches in the United Kingdom alone amount to over £4 billion per annum Reklaim has centred its business model around enabling users to reclaim their data, delete it or in its stead, monetize it The company recently entered a non-binding letter of intent to purchase US-based Multimedia Lists to expand its top-line revenue and profitability further In 2004, Philip…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered